Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Honda Motor Co., Ltd. (HMC) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Honda Motor Co., Ltd. (HMC) - free report >>
Image: Bigstock
Best Value Stocks to Buy for February 29th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, February 29:
Ultrapar Participações S.A. (UGP - Free Report) : This energy and infrastructure company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 31.8% over the last 60 days.
Ultrapar Participacoes S.A. Price and Consensus
Ultrapar Participacoes S.A. price-consensus-chart | Ultrapar Participacoes S.A. Quote
Ultrapar Participações has a price-to-earnings ratio (P/E) of 19.66 compared with 22.57 for the S&P. The company possesses a Value Score of B.
Ultrapar Participacoes S.A. PE Ratio (TTM)
Ultrapar Participacoes S.A. pe-ratio-ttm | Ultrapar Participacoes S.A. Quote
Honda Motor Co., Ltd. (HMC - Free Report) : This automobile company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.3% over the last 60 days.
Honda Motor Co., Ltd. Price and Consensus
Honda Motor Co., Ltd. price-consensus-chart | Honda Motor Co., Ltd. Quote
Honda Motor Co has a price-to-earnings ratio (P/E) of 8.45 compared with 21.50 for the S&P. The company possesses a Value Score of A.
Honda Motor Co., Ltd. PE Ratio (TTM)
Honda Motor Co., Ltd. pe-ratio-ttm | Honda Motor Co., Ltd. Quote
Collegium Pharmaceutical, Inc. (COLL - Free Report) : This pharmaceutical company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 6.7% over the last 60 days.
Collegium Pharmaceutical, Inc. Price and Consensus
Collegium Pharmaceutical, Inc. price-consensus-chart | Collegium Pharmaceutical, Inc. Quote
Collegium Pharmaceutical has a price-to-earnings ratio (P/E) of 6.19 compared with 21.50 for the S&P. The company possesses a Value Score of A.
Collegium Pharmaceutical, Inc. PE Ratio (TTM)
Collegium Pharmaceutical, Inc. pe-ratio-ttm | Collegium Pharmaceutical, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.